Re: Clinical Efficacy of Collagenase Clostridium histolyticum in the Treatment of Peyronie's Disease by Subgroups: Results from Two Large, Double-blind, Randomized, Placebo-controlled, Phase III Studies

被引：3
|
作者：
Kadioglu, Ates [1 ]
Boyuk, Abubekir [1 ]
Salabas, Emre [1 ]
机构：
[1] Istanbul Univ, Istanbul Fac Med, Sect Androl, Istanbul, Turkey
来源：
EUROPEAN UROLOGY | 2015年 / 68卷 / 05期
关键词：
QUESTIONNAIRE; SAFETY;
D O I：
10.1016/j.eururo.2015.07.067
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：908 / 909
页数：3
相关论文
共 50 条
  • [31] Re: Efficacy of Everolimus in Advanced Renal Cell Carcinoma: A Double-Blind, Randomized, Placebo-Controlled Phase III Trial
    Culp, Stephen H.
    Wood, Christopher G.
    EUROPEAN UROLOGY, 2009, 55 (06) : 1484 - 1485
  • [32] Therapeutic effects of colchicine in the management of Peyronie's disease: a randomized double-blind, placebo-controlled study
    Safarinejad, MR
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2004, 16 (03) : 238 - 243
  • [33] Therapeutic effects of colchicine in the management of Peyronie's disease: a randomized double-blind, placebo-controlled study
    M R Safarinejad
    International Journal of Impotence Research, 2004, 16 : 238 - 243
  • [34] Adapalene 0.1% Lotion in the Treatment of Acne Vulgaris: Results From Two Placebo-controlled, Multicenter, Randomized Double-blind, Clinical Studies
    Eichenfield, Lawrence F.
    Jarratt, Michael
    Schlessinger, Joel
    Kempers, Steven
    Manna, Vasant
    Hwa, Joyce
    Liu, Yin
    Graeber, Michael
    JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (06) : 639 - 646
  • [35] Commentary on Collagenase Clostridium Histolyticum-Aaes for the Treatment of Cellulite in Women: Results From 2 Phase 3 Randomized, Placebo-Controlled Trials
    Draelos, Zoe Diana
    DERMATOLOGIC SURGERY, 2021, 47 (05) : 657 - 657
  • [36] BRIVARACETAM IN PATIENTS WITH UNVERRICHT-LUNDBORG DISEASE: RESULTS FROM TWO RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDIES
    Kalviaiinen, R.
    Genton, P.
    Andermann, E.
    Magaudda, A.
    Frucht, S.
    Schlit, A.
    Gerard, D.
    Van Otterdijk, E.
    von Rosenstiel, P.
    EPILEPSIA, 2009, 50 : 47 - 47
  • [37] Efficacy and Safety of Golimumab in Patients With Ankylosing Spondylitis Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial
    Inman, Robert D.
    Davis, John C., Jr.
    van der Heijde, Desiree
    Dickman, Laura
    Sieper, Joachim
    Kim, Sung Il
    Mack, Michael
    Han, John
    Visvanathan, Sudha
    Xu, Zhenhua
    Su, Benjamin
    Beutler, Anna
    Braun, Juergen
    ARTHRITIS AND RHEUMATISM, 2008, 58 (11): : 3402 - 3412
  • [38] Methotrexate in Crohn's disease: Results of a randomized, double-blind, placebo-controlled trial
    Arora, S
    Katkov, W
    Cooley, J
    Kemp, JA
    Johnston, DE
    Schapiro, RH
    Podolsky, D
    HEPATO-GASTROENTEROLOGY, 1999, 46 (27) : 1724 - 1729
  • [39] Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer's Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study
    Gold, Michael
    Alderton, Claire
    Zvartau-Hind, Marina
    Egginton, Sally
    Saunders, Ann M.
    Irizarry, Michael
    Craft, Suzanne
    Landreth, Gary
    Linnamaegi, Uella
    Sawchak, Sharon
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2010, 30 (02) : 131 - 146
  • [40] EFFICACY AND SAFETY OF EBRONUCIMAB, IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA AND MIXED HYPERLIPIDEMIA: RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III CLINICAL STUDY
    Huo, Y.
    Zheng, B.
    Xia, Y.
    Wang, M.
    Li, B.
    Ni, X.
    Wang, G.
    Yu, B.
    ATHEROSCLEROSIS, 2023, 379 : S198 - S199
12345